TOP TIERMARKET NEWSWIRE
News & sentiment

FAETH THERAPEUTICS I (FTH) — News & AI sentiment

FAETH THERAPEUTICS I (FTH) news roundup. 3 stories in the past week, 12 over 30 days. Average 30-day sentiment is 58.7/100. Recent insider activity (SEC Form 4, 90-day window): 4 purchases totalling $1.2M and 0 sales totalling $0 — net buying of $1.2M. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
3
avg sentiment 59.3/100
30d stories
12
avg sentiment 58.7/100
Insider net (90d)
$1.2M
4 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

FTH news in the last 24 hours, 7 days, 30 days and 90 days

How much FTH coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowFTH storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days359.3/100FTH headlines →
Last 30 days1258.7/100FTH headlines →
Last 90 days2954.7/100FTH headlines →

Latest stories on FTH

TD Cowen initiates Faeth Therapeutics stock with buy rating
Investing.com Analyst Ratings61 · neutralanalyst
4d ago
4d ago
5d ago
Sep 1
Aug 28
Aug 21
Aug 21
Aug 17
Why is Faeth Therapeutics stock surging today?
Investing.com Markets50 · neutralgeneral
Aug 17
Aug 17
Aug 17
Aug 16
Aug 14
Aug 11
Aug 7
Aug 7
Sensei Biotherapeutics GAAP EPS of -$2.84
Seeking Alpha32 · bearishearnings
Aug 4
Faeth Therapeutics, Inc. (FTH) files 8-K
SEC 8-K50 · neutralgeneral
Aug 4
Aug 4
Raymond James initiates Faeth Therapeutics stock with outperform rating
Investing.com Analyst Ratings61 · neutralanalyst
Jul 31
Oppenheimer initiates Faeth Therapeutics stock with outperform rating
Investing.com Analyst Ratings61 · neutralanalyst
Jul 27
Jul 23
Faeth Therapeutics, Inc. (FTH) files 8-K
SEC 8-K50 · neutralgeneral
Jul 23
Jul 23
Citizens initiates Faeth Therapeutics stock at outperform, $51 target
Investing.com Analyst Ratings61 · neutralanalyst
Jul 20
Open FTH in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →